Arbutus Biopharma
ABUS
#7051
Rank
โ‚ฌ0.56 B
Marketcap
3,66ย โ‚ฌ
Share price
-1.23%
Change (1 day)
-2.08%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): 0,71ย โ‚ฌ

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is 0,75ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,15ย โ‚ฌ an increase over its 2024 EPS that were of -0,35ย โ‚ฌ.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)0,71ย โ‚ฌ-557.13%
2025-0,15ย โ‚ฌ-55.26%
2024-0,35ย โ‚ฌ-13.64%
2023-0,40ย โ‚ฌ-4.35%
2022-0,42ย โ‚ฌ-44.58%
2021-0,76ย โ‚ฌ-17%
2020-0,91ย โ‚ฌ-65.4%
2019-2,63ย โ‚ฌ138.84%
2018-1,10ย โ‚ฌ-22.44%
2017-1,42ย โ‚ฌ-78.45%
2016-6,60ย โ‚ฌ424.64%
2015-1,26ย โ‚ฌ-20.19%
2014-1,58ย โ‚ฌ87.96%
2013-0,84ย โ‚ฌ-142.59%
20121,97ย โ‚ฌ-342.7%
2011-0,81ย โ‚ฌ-25.82%
2010-1,09ย โ‚ฌ47.8%
2009-0,74ย โ‚ฌ-43.55%
2008-1,31ย โ‚ฌ158.91%
2007-0,51ย โ‚ฌ-111.88%
20064,26ย โ‚ฌ-552.53%
2005-0,94ย โ‚ฌ-71.77%
2004-3,34ย โ‚ฌ-14.48%
2003-3,90ย โ‚ฌ-8.95%
2002-4,28ย โ‚ฌ70.07%
2001-2,52ย โ‚ฌ48.01%
2000-1,70ย โ‚ฌ-33.51%
1999-2,56ย โ‚ฌ-24.6%
1998-3,40ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-0,05470ย โ‚ฌ-107.32% Bahamas
NRC Health
NRC
0,26ย โ‚ฌ-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA